Biotech investor Flagship Pioneering has raised $3.6 billion dollars for ventures in health, sustainability and AI. With $14 billion dollars of assets under management, it ranks among the top biotech investors globally. The firm has launched and invested in dozens of companies including Moderna. Noubar Afeyan, Flagship's Chief Executive and Founder, as well as the Co-founder of Moderna, spoke to Bloomberg's Francine Lacqua.